Last reviewed: July 10, 2026
Last updated: July 10, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide injections work best when administered to the right body locations using proper rotation patterns. Most patients experience optimal results when they follow a systematic site-rotation schedule that prevents lipohypertrophy and ensures steady medication absorption. Understanding where and how to inject your weekly dose helps maximize therapeutic benefit while minimizing injection-related discomfort.
Approved Semaglutide Injection Sites and Anatomy
Semaglutide is a subcutaneous injection, meaning it goes into the fatty tissue just under your skin rather than into muscle or veins. Three body areas are approved for semaglutide administration: the abdomen, the upper arm, and the thigh. Each location has distinct advantages depending on your comfort level, ease of access, and daily routine. The abdomen offers the largest injection area and easiest self-administration for most patients. The upper arm and thigh provide excellent alternatives when you need variety in your rotation schedule.
Subcutaneous injection sites contain adequate fat padding that allows medication to absorb slowly and consistently into your bloodstream. Avoid injecting directly over bones, joints, or areas with active bruising, rash, or inflammation. If you have significant scarring from prior injections or surgery, space new injections at least one inch away from affected tissue. Rotating systematically across your three approved zones reduces the risk of tissue damage and maintains predictable medication delivery over weeks and months of treatment.
Creating an Effective Injection Rotation Schedule
A rotation schedule prevents lipohypertrophy, a condition where repeated injections in the same spot cause fatty tissue to thicken or develop lumps. This thickened tissue absorbs medication unevenly, potentially reducing how well semaglutide works and increasing injection discomfort. PlexusDx recommends rotating between at least four different injection sites per week to spread stress across your tissue. One common pattern uses the right abdomen one week, left abdomen the next week, then alternates to the thigh and upper arm in subsequent weeks.
Spacing new injections at least one inch apart from previous injection sites gives tissue time to heal between doses. Keep a simple log or use your phone's calendar to track which area you used each week. This prevents accidentally re-injecting the same spot and helps you identify any areas where you notice bruising, numbness, or persistent discomfort. Many patients find that alternating between abdomen, thigh, and arm in a four-week cycle feels natural and easy to remember.
Technique, Angle, and Depth for Safe Administration
Proper injection technique ensures your semaglutide reaches subcutaneous tissue rather than penetrating too deeply or staying too shallow. Hold the syringe or pen at a 45 to 90-degree angle to your skin—most people find a 90-degree angle (perpendicular) easiest to execute consistently. Pinch a fold of skin and fatty tissue between your thumb and fingers to ensure adequate depth, then insert the needle smoothly through the skin into the fat layer. Press the plunger or activation button slowly to deliver the full dose over several seconds rather than rushing, which reduces tissue trauma.
After injecting, leave the needle in place for three seconds before withdrawing to allow the medication to distribute properly and prevent backflow. Remove the needle at the same angle you inserted it, then release the pinched skin. Do not rub the injection site afterward—this can increase bruising and alter absorption patterns. If you notice blood on the surface, apply gentle pressure with a clean cloth for one minute. Minor bruising is normal and typically fades within days without affecting medication efficacy.
Addressing Pain, Bruising, and Injection Site Reactions
Most patients experience minimal pain with semaglutide injections because the needle is thin and the medication volume is small. Sharp pain during injection usually signals the needle has hit a nerve or blood vessel—withdraw immediately and choose a different site. Mild stinging that fades within seconds is normal and typically indicates proper subcutaneous placement. Using ice for one minute before injection can numb the area and reduce discomfort. Allowing your medication to reach room temperature before injection also decreases injection-site discomfort compared to cold medication straight from the refrigerator.
Light bruising around injection sites is common and not dangerous, but persistent bruising, warmth, redness, or swelling extending beyond one inch from the injection site warrants evaluation. These signs may indicate infection, excessive tissue trauma, or lipohypertrophy. If you develop a hard lump, dimple, or raised area at an injection site that doesn't resolve within two weeks, contact PlexusDx or your healthcare provider. Proper rotation technique and site spacing typically prevent these complications, and most injection-site reactions resolve without intervention.
How PlexusDx Personalizes Your Semaglutide Treatment Plan
PlexusDx offers compounded semaglutide injections starting at $189/mo (or $149/mo on the 6-month plan) through licensed 503A compounding pharmacies, with no insurance requirement and HSA/FSA eligibility. Your dosing schedule and potential dose adjustments depend on your individual response, not your monthly cost—a core PlexusDx principle is that your dose may need to go up, but your price won't. Whether you start at a lower maintenance dose or require escalation over weeks, your monthly investment remains consistent, making long-term GLP-1 therapy predictable and affordable.
The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R (rs6923761), and GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $189/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I use any part of my abdomen for semaglutide injections?
Yes, the abdomen is a large approved injection area. Rotate across different zones: upper right, upper left, lower right, and lower left quadrants, spaced at least one inch apart. This spreads injection trauma across a wide tissue area and significantly reduces the risk of developing lipohypertrophy or hard lumps.
What happens if I inject semaglutide into a bruised or lumpy area?
Injecting into existing bruising or lipohypertrophy (lumpy tissue) can cause pain and may result in unpredictable medication absorption. Always select a healthy, smooth injection site at least one inch away from any previous injection marks, bruises, or raised areas. Proper rotation prevents these complications from developing.
How much does semaglutide cost at PlexusDx, and does price change with dose increases?
PlexusDx compounded semaglutide starts at $189 per month with no insurance required and HSA/FSA eligibility. Your dose may increase during treatment, but your monthly price remains flat—a key difference from many competitors. PlexusDx serves all 50 states with no membership fees.
Is minor bleeding or bruising after a semaglutide injection normal?
Yes, light bruising and minor surface bleeding are normal and not dangerous. Bruises typically fade within days without affecting medication effectiveness. However, persistent swelling, warmth, or redness extending beyond one inch from the injection site may indicate infection and warrants medical evaluation.
Can genetic testing help me optimize my semaglutide injection response?
No — the Precision Peptide Genetic Test does not predict your response to Wegovy or any specific medication. It analyzes pathway-level variants (GLP1R (rs6923761), and GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Why Do You Lose Weight with Mounjaro?
Sermorelin and Ozempic Together — Safe Combination Protocol